Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by:
Taipei Medical University WanFang Hospital
ClinicalTrials.gov Identifier:
NCT01369992
First received: June 8, 2011
Last updated: NA
Last verified: June 2011
History: No changes posted

June 8, 2011
June 8, 2011
May 2011
Not Provided
Not Provided
Not Provided
No Changes Posted
Not Provided
Not Provided
Not Provided
Not Provided
 
Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites
Molecular Profiling of Metastatic Cancer in Pleural Effusion and Ascites

Cancers are among the most frequent leading causes of death in Taiwan, and many of them show their respective unique epidemiological and pathophysiological features in Taiwanese population. One of the distinguishing features of cancers includes their potential to metastasize outside the primary tumor. Pleural cavity and peritoneum are two of the most frequent sites of metastases when serosal surfaces are involved. The prognoses of such patients are extremely poor with a median survival of months. The understandings of cancer biology of tumor metastasis demand more in-depth studies at the molecular and cell levels. Studies based on cell culture are excellent approaches for this purpose as the cell culture provides a relevant and renewable model for studying the pathological and molecular changes underlying human malignant tumors.

Due to their easy accessibility, pleural effusions and ascites are two important clinical sources of metastatic cancer cells, which upon isolation, permit comparative studies between the biology nature of primary tumor and metastatic ones. In this study, we will try to isolate cancer cells from human malignant effusions, said to be pleural effusions and/or ascites. We will establish phenotypic alterations along the progression of malignant tumors with serosal metastasis, with special emphasis on expression of some proteases, laminin receptors and transcription factors involved in the process of invasion and metastasis. We would also perform clinical correlations, including tumor type, staging, status of lymph node metastasis and histopathological differentiation and grading, etc.

Observational
Not Provided
Not Provided
Not Provided
Non-Probability Sample

cancer patients

Metastatic Cancer
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Active, not recruiting
20
May 2013
Not Provided

Inclusion Criteria:

  • cancer patients
  • pleural effusion or peritoneal effusion

Exclusion Criteria:

  • infected and fever patients
  • anticoagulant treatment patients
  • patients don't attend this study
Both
20 Years and older
No
Contact information is only displayed when the study is recruiting subjects
Taiwan
 
NCT01369992
99048
No
Tze-Sian Chan, Department of Gastroenterology
Taipei Medical University WanFang Hospital
Not Provided
Principal Investigator: Tze-Sian Chan Taipei Medical University WanFang Hospital
Taipei Medical University WanFang Hospital
June 2011

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP